1. Méthodologie pour l’évaluation du niveau de preuve du suivi thérapeutique pharmacologique;Le Guellec;La lettre du pharmacologue,2009
2. http://www.ema.europa.eu/humandocs/PDFs/EPAR/Paxene/H-216-PI-en.pdf
3. Bioanalysis, pharmacokinetics, and pharmacodynamics of the novel anticancer drug paclitaxel (Taxol);Beijnen;Semin. Oncol.,1994
4. Weekly administration of paclitaxel: theoretical and clinical basis;Marchetti;Crit. Rev. Oncol. Hematol.,2002
5. Role of cytochrome P450 activity in the fate of anticancer agents and in drug resistance: focus on tamoxifen, paclitaxel and imatinib metabolism;Rochat;Clin. Pharmacokinet.,2005